FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer By Ogkologos - June 27, 2025 403 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ARANOTE study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Workout Wednesday – Back Stretches Part 2 July 29, 2020 Bean there done that: Can swapping to pulses be the new... February 11, 2022 Daughter Surprises Terminally Ill Mom With Graduation Ceremony In Hospital Room. May 16, 2019 Delivering Palliative Care by Telehealth Meets the Needs of People with... October 28, 2024 Load more HOT NEWS Patient Guide in Testicular Cancer Now Available Also in French What to Know About Getting Access to New Cancer Advances Presented... Reflecting On My Time As the Cancer.Net Editor in Chief Why Wearing Comfortable Clothes During Cancer Treatment Matters
